 | • レポートコード：MRC2-11QY01669 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は感染性ワクチンのグローバル市場について調査・分析したレポートです。種類別（予防ワクチン、治療ワクチン）市場規模、用途別（大人、小児科）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別感染性ワクチンの競争状況、市場シェア ・世界の感染性ワクチン市場：種類別市場規模 2015年-2020年（予防ワクチン、治療ワクチン） ・世界の感染性ワクチン市場：種類別市場規模予測 2021年-2026年（予防ワクチン、治療ワクチン） ・世界の感染性ワクチン市場：用途別市場規模 2015年-2020年（大人、小児科） ・世界の感染性ワクチン市場：用途別市場規模予測 2021年-2026年（大人、小児科） ・北米の感染性ワクチン市場分析：米国、カナダ ・ヨーロッパの感染性ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの感染性ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の感染性ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの感染性ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：CSL Limited (Australia)、Bavarian Nordic (Denmark)、GlaxoSmithKline plc. (U.K.)、Emergent Bio Solutions Inc. (U.S.)、MedImmune LLC (U.S.)、Johnson and Johnson (U.S.)、Novartis AG (Switzerland)、Merck and Company (U.S.)、Sanofi Pasteur (France)、Pfizer Inc. (U.S.) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.
Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.
Market Analysis and Insights: Global Infectious Vaccines Market
The global Infectious Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Infectious Vaccines Scope and Market Size
Infectious Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Infectious Vaccines market is segmented into
Preventive vaccine
Therapeutic vaccine
Segment by Application, the Infectious Vaccines market is segmented into
Adults
Pediatrics
Regional and Country-level Analysis
The Infectious Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Infectious Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Infectious Vaccines Market Share Analysis
Infectious Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Infectious Vaccines business, the date to enter into the Infectious Vaccines market, Infectious Vaccines product introduction, recent developments, etc.
The major vendors covered:
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc. (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Sanofi Pasteur (France)
Pfizer Inc. (U.S.)
1 Study Coverage
1.1 Infectious Vaccines Product Introduction
1.2 Market Segments
1.3 Key Infectious Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Infectious Vaccines Market Size Growth Rate by Type
1.4.2 Preventive vaccine
1.4.3 Therapeutic vaccine
1.5 Market by Application
1.5.1 Global Infectious Vaccines Market Size Growth Rate by Application
1.5.2 Adults
1.5.3 Pediatrics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Infectious Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Infectious Vaccines Revenue 2015-2026
2.1.2 Global Infectious Vaccines Sales 2015-2026
2.2 Global Infectious Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Infectious Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Infectious Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Infectious Vaccines Competitor Landscape by Players
3.1 Infectious Vaccines Sales by Manufacturers
3.1.1 Infectious Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Infectious Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Infectious Vaccines Revenue by Manufacturers
3.2.1 Infectious Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Infectious Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Infectious Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Infectious Vaccines Revenue in 2019
3.2.5 Global Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Infectious Vaccines Price by Manufacturers
3.4 Infectious Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Infectious Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Infectious Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Infectious Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Infectious Vaccines Market Size by Type (2015-2020)
4.1.1 Global Infectious Vaccines Sales by Type (2015-2020)
4.1.2 Global Infectious Vaccines Revenue by Type (2015-2020)
4.1.3 Infectious Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Infectious Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Infectious Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Infectious Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Infectious Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Infectious Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Infectious Vaccines Market Size by Application (2015-2020)
5.1.1 Global Infectious Vaccines Sales by Application (2015-2020)
5.1.2 Global Infectious Vaccines Revenue by Application (2015-2020)
5.1.3 Infectious Vaccines Price by Application (2015-2020)
5.2 Infectious Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Infectious Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Infectious Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Infectious Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Infectious Vaccines by Country
6.1.1 North America Infectious Vaccines Sales by Country
6.1.2 North America Infectious Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Infectious Vaccines Market Facts & Figures by Type
6.3 North America Infectious Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Infectious Vaccines by Country
7.1.1 Europe Infectious Vaccines Sales by Country
7.1.2 Europe Infectious Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Infectious Vaccines Market Facts & Figures by Type
7.3 Europe Infectious Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Infectious Vaccines by Region
8.1.1 Asia Pacific Infectious Vaccines Sales by Region
8.1.2 Asia Pacific Infectious Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Infectious Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Infectious Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Infectious Vaccines by Country
9.1.1 Latin America Infectious Vaccines Sales by Country
9.1.2 Latin America Infectious Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Infectious Vaccines Market Facts & Figures by Type
9.3 Central & South America Infectious Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Infectious Vaccines by Country
10.1.1 Middle East and Africa Infectious Vaccines Sales by Country
10.1.2 Middle East and Africa Infectious Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Infectious Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Infectious Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 CSL Limited (Australia)
11.1.1 CSL Limited (Australia) Corporation Information
11.1.2 CSL Limited (Australia) Description and Business Overview
11.1.3 CSL Limited (Australia) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CSL Limited (Australia) Infectious Vaccines Products Offered
11.1.5 CSL Limited (Australia) Related Developments
11.2 Bavarian Nordic (Denmark)
11.2.1 Bavarian Nordic (Denmark) Corporation Information
11.2.2 Bavarian Nordic (Denmark) Description and Business Overview
11.2.3 Bavarian Nordic (Denmark) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bavarian Nordic (Denmark) Infectious Vaccines Products Offered
11.2.5 Bavarian Nordic (Denmark) Related Developments
11.3 GlaxoSmithKline plc. (U.K.)
11.3.1 GlaxoSmithKline plc. (U.K.) Corporation Information
11.3.2 GlaxoSmithKline plc. (U.K.) Description and Business Overview
11.3.3 GlaxoSmithKline plc. (U.K.) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Products Offered
11.3.5 GlaxoSmithKline plc. (U.K.) Related Developments
11.4 Emergent Bio Solutions Inc. (U.S.)
11.4.1 Emergent Bio Solutions Inc. (U.S.) Corporation Information
11.4.2 Emergent Bio Solutions Inc. (U.S.) Description and Business Overview
11.4.3 Emergent Bio Solutions Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Products Offered
11.4.5 Emergent Bio Solutions Inc. (U.S.) Related Developments
11.5 MedImmune LLC (U.S.)
11.5.1 MedImmune LLC (U.S.) Corporation Information
11.5.2 MedImmune LLC (U.S.) Description and Business Overview
11.5.3 MedImmune LLC (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 MedImmune LLC (U.S.) Infectious Vaccines Products Offered
11.5.5 MedImmune LLC (U.S.) Related Developments
11.6 Johnson and Johnson (U.S.)
11.6.1 Johnson and Johnson (U.S.) Corporation Information
11.6.2 Johnson and Johnson (U.S.) Description and Business Overview
11.6.3 Johnson and Johnson (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson and Johnson (U.S.) Infectious Vaccines Products Offered
11.6.5 Johnson and Johnson (U.S.) Related Developments
11.7 Novartis AG (Switzerland)
11.7.1 Novartis AG (Switzerland) Corporation Information
11.7.2 Novartis AG (Switzerland) Description and Business Overview
11.7.3 Novartis AG (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novartis AG (Switzerland) Infectious Vaccines Products Offered
11.7.5 Novartis AG (Switzerland) Related Developments
11.8 Merck and Company (U.S.)
11.8.1 Merck and Company (U.S.) Corporation Information
11.8.2 Merck and Company (U.S.) Description and Business Overview
11.8.3 Merck and Company (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck and Company (U.S.) Infectious Vaccines Products Offered
11.8.5 Merck and Company (U.S.) Related Developments
11.9 Sanofi Pasteur (France)
11.9.1 Sanofi Pasteur (France) Corporation Information
11.9.2 Sanofi Pasteur (France) Description and Business Overview
11.9.3 Sanofi Pasteur (France) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sanofi Pasteur (France) Infectious Vaccines Products Offered
11.9.5 Sanofi Pasteur (France) Related Developments
11.10 Pfizer Inc. (U.S.)
11.10.1 Pfizer Inc. (U.S.) Corporation Information
11.10.2 Pfizer Inc. (U.S.) Description and Business Overview
11.10.3 Pfizer Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Pfizer Inc. (U.S.) Infectious Vaccines Products Offered
11.10.5 Pfizer Inc. (U.S.) Related Developments
11.1 CSL Limited (Australia)
11.1.1 CSL Limited (Australia) Corporation Information
11.1.2 CSL Limited (Australia) Description and Business Overview
11.1.3 CSL Limited (Australia) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CSL Limited (Australia) Infectious Vaccines Products Offered
11.1.5 CSL Limited (Australia) Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Infectious Vaccines Market Estimates and Projections by Region
12.1.1 Global Infectious Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Infectious Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Infectious Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Infectious Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Infectious Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Infectious Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Infectious Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Infectious Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Infectious Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Infectious Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Infectious Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Infectious Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Infectious Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Infectious Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Infectious Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Infectious Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Infectious Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Infectious Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Infectious Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Infectious Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Infectious Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Infectious Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Infectious Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Infectious Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Infectious Vaccines Market Segments
Table 2. Ranking of Global Top Infectious Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Infectious Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Preventive vaccine
Table 5. Major Manufacturers of Therapeutic vaccine
Table 6. Global Infectious Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Infectious Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Infectious Vaccines Sales by Regions 2015-2020 (K Units)
Table 9. Global Infectious Vaccines Sales Market Share by Regions (2015-2020)
Table 10. Global Infectious Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Infectious Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Infectious Vaccines Sales Share by Manufacturers (2015-2020)
Table 13. Global Infectious Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Infectious Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Vaccines as of 2019)
Table 15. Infectious Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Infectious Vaccines Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Infectious Vaccines Price (2015-2020) (USD/Unit)
Table 18. Infectious Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Infectious Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Infectious Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Infectious Vaccines Sales by Type (2015-2020) (K Units)
Table 23. Global Infectious Vaccines Sales Share by Type (2015-2020)
Table 24. Global Infectious Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Infectious Vaccines Revenue Share by Type (2015-2020)
Table 26. Infectious Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Infectious Vaccines Sales by Application (2015-2020) (K Units)
Table 28. Global Infectious Vaccines Sales Share by Application (2015-2020)
Table 29. North America Infectious Vaccines Sales by Country (2015-2020) (K Units)
Table 30. North America Infectious Vaccines Sales Market Share by Country (2015-2020)
Table 31. North America Infectious Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Infectious Vaccines Revenue Market Share by Country (2015-2020)
Table 33. North America Infectious Vaccines Sales by Type (2015-2020) (K Units)
Table 34. North America Infectious Vaccines Sales Market Share by Type (2015-2020)
Table 35. North America Infectious Vaccines Sales by Application (2015-2020) (K Units)
Table 36. North America Infectious Vaccines Sales Market Share by Application (2015-2020)
Table 37. Europe Infectious Vaccines Sales by Country (2015-2020) (K Units)
Table 38. Europe Infectious Vaccines Sales Market Share by Country (2015-2020)
Table 39. Europe Infectious Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Infectious Vaccines Revenue Market Share by Country (2015-2020)
Table 41. Europe Infectious Vaccines Sales by Type (2015-2020) (K Units)
Table 42. Europe Infectious Vaccines Sales Market Share by Type (2015-2020)
Table 43. Europe Infectious Vaccines Sales by Application (2015-2020) (K Units)
Table 44. Europe Infectious Vaccines Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Infectious Vaccines Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Infectious Vaccines Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Infectious Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Infectious Vaccines Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Infectious Vaccines Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Infectious Vaccines Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Infectious Vaccines Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Infectious Vaccines Sales Market Share by Application (2015-2020)
Table 53. Latin America Infectious Vaccines Sales by Country (2015-2020) (K Units)
Table 54. Latin America Infectious Vaccines Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Infectious Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Infectious Vaccines Revenue Market Share by Country (2015-2020)
Table 57. Latin America Infectious Vaccines Sales by Type (2015-2020) (K Units)
Table 58. Latin America Infectious Vaccines Sales Market Share by Type (2015-2020)
Table 59. Latin America Infectious Vaccines Sales by Application (2015-2020) (K Units)
Table 60. Latin America Infectious Vaccines Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Infectious Vaccines Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Infectious Vaccines Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Infectious Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Infectious Vaccines Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Infectious Vaccines Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Infectious Vaccines Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Infectious Vaccines Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Infectious Vaccines Sales Market Share by Application (2015-2020)
Table 69. CSL Limited (Australia) Corporation Information
Table 70. CSL Limited (Australia) Description and Major Businesses
Table 71. CSL Limited (Australia) Infectious Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. CSL Limited (Australia) Product
Table 73. CSL Limited (Australia) Recent Development
Table 74. Bavarian Nordic (Denmark) Corporation Information
Table 75. Bavarian Nordic (Denmark) Description and Major Businesses
Table 76. Bavarian Nordic (Denmark) Infectious Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Bavarian Nordic (Denmark) Product
Table 78. Bavarian Nordic (Denmark) Recent Development
Table 79. GlaxoSmithKline plc. (U.K.) Corporation Information
Table 80. GlaxoSmithKline plc. (U.K.) Description and Major Businesses
Table 81. GlaxoSmithKline plc. (U.K.) Infectious Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. GlaxoSmithKline plc. (U.K.) Product
Table 83. GlaxoSmithKline plc. (U.K.) Recent Development
Table 84. Emergent Bio Solutions Inc. (U.S.) Corporation Information
Table 85. Emergent Bio Solutions Inc. (U.S.) Description and Major Businesses
Table 86. Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Emergent Bio Solutions Inc. (U.S.) Product
Table 88. Emergent Bio Solutions Inc. (U.S.) Recent Development
Table 89. MedImmune LLC (U.S.) Corporation Information
Table 90. MedImmune LLC (U.S.) Description and Major Businesses
Table 91. MedImmune LLC (U.S.) Infectious Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. MedImmune LLC (U.S.) Product
Table 93. MedImmune LLC (U.S.) Recent Development
Table 94. Johnson and Johnson (U.S.) Corporation Information
Table 95. Johnson and Johnson (U.S.) Description and Major Businesses
Table 96. Johnson and Johnson (U.S.) Infectious Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Johnson and Johnson (U.S.) Product
Table 98. Johnson and Johnson (U.S.) Recent Development
Table 99. Novartis AG (Switzerland) Corporation Information
Table 100. Novartis AG (Switzerland) Description and Major Businesses
Table 101. Novartis AG (Switzerland) Infectious Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Novartis AG (Switzerland) Product
Table 103. Novartis AG (Switzerland) Recent Development
Table 104. Merck and Company (U.S.) Corporation Information
Table 105. Merck and Company (U.S.) Description and Major Businesses
Table 106. Merck and Company (U.S.) Infectious Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Merck and Company (U.S.) Product
Table 108. Merck and Company (U.S.) Recent Development
Table 109. Sanofi Pasteur (France) Corporation Information
Table 110. Sanofi Pasteur (France) Description and Major Businesses
Table 111. Sanofi Pasteur (France) Infectious Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Sanofi Pasteur (France) Product
Table 113. Sanofi Pasteur (France) Recent Development
Table 114. Pfizer Inc. (U.S.) Corporation Information
Table 115. Pfizer Inc. (U.S.) Description and Major Businesses
Table 116. Pfizer Inc. (U.S.) Infectious Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Pfizer Inc. (U.S.) Product
Table 118. Pfizer Inc. (U.S.) Recent Development
Table 119. Global Infectious Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 120. Global Infectious Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Infectious Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Infectious Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Infectious Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 124. North America: Infectious Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Infectious Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 126. Europe: Infectious Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Infectious Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 128. Asia Pacific: Infectious Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Infectious Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 130. Latin America: Infectious Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Infectious Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 132. Middle East and Africa: Infectious Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Infectious Vaccines Players
Table 137. Infectious Vaccines Customers List
Table 138. Infectious Vaccines Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Infectious Vaccines Product Picture
Figure 2. Global Infectious Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Preventive vaccine Product Picture
Figure 4. Therapeutic vaccine Product Picture
Figure 5. Global Infectious Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Adults
Figure 7. Pediatrics
Figure 8. Infectious Vaccines Report Years Considered
Figure 9. Global Infectious Vaccines Market Size 2015-2026 (US$ Million)
Figure 10. Global Infectious Vaccines Sales 2015-2026 (K Units)
Figure 11. Global Infectious Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Infectious Vaccines Sales Market Share by Region (2015-2020)
Figure 13. Global Infectious Vaccines Sales Market Share by Region in 2019
Figure 14. Global Infectious Vaccines Revenue Market Share by Region (2015-2020)
Figure 15. Global Infectious Vaccines Revenue Market Share by Region in 2019
Figure 16. Global Infectious Vaccines Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Infectious Vaccines Revenue in 2019
Figure 18. Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Infectious Vaccines Sales Market Share by Type (2015-2020)
Figure 20. Global Infectious Vaccines Sales Market Share by Type in 2019
Figure 21. Global Infectious Vaccines Revenue Market Share by Type (2015-2020)
Figure 22. Global Infectious Vaccines Revenue Market Share by Type in 2019
Figure 23. Global Infectious Vaccines Market Share by Price Range (2015-2020)
Figure 24. Global Infectious Vaccines Sales Market Share by Application (2015-2020)
Figure 25. Global Infectious Vaccines Sales Market Share by Application in 2019
Figure 26. Global Infectious Vaccines Revenue Market Share by Application (2015-2020)
Figure 27. Global Infectious Vaccines Revenue Market Share by Application in 2019
Figure 28. North America Infectious Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Infectious Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Infectious Vaccines Sales Market Share by Country in 2019
Figure 31. North America Infectious Vaccines Revenue Market Share by Country in 2019
Figure 32. U.S. Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Infectious Vaccines Market Share by Type in 2019
Figure 37. North America Infectious Vaccines Market Share by Application in 2019
Figure 38. Europe Infectious Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Infectious Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Infectious Vaccines Sales Market Share by Country in 2019
Figure 41. Europe Infectious Vaccines Revenue Market Share by Country in 2019
Figure 42. Germany Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Infectious Vaccines Market Share by Type in 2019
Figure 53. Europe Infectious Vaccines Market Share by Application in 2019
Figure 54. Asia Pacific Infectious Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Infectious Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Infectious Vaccines Sales Market Share by Region in 2019
Figure 57. Asia Pacific Infectious Vaccines Revenue Market Share by Region in 2019
Figure 58. China Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Infectious Vaccines Market Share by Type in 2019
Figure 81. Asia Pacific Infectious Vaccines Market Share by Application in 2019
Figure 82. Latin America Infectious Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Infectious Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Infectious Vaccines Sales Market Share by Country in 2019
Figure 85. Latin America Infectious Vaccines Revenue Market Share by Country in 2019
Figure 86. Mexico Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Infectious Vaccines Market Share by Type in 2019
Figure 93. Latin America Infectious Vaccines Market Share by Application in 2019
Figure 94. Middle East and Africa Infectious Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Infectious Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Infectious Vaccines Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Infectious Vaccines Revenue Market Share by Country in 2019
Figure 98. Turkey Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Infectious Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Infectious Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Infectious Vaccines Market Share by Type in 2019
Figure 105. Middle East and Africa Infectious Vaccines Market Share by Application in 2019
Figure 106. North America Infectious Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 107. North America Infectious Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Infectious Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. Europe Infectious Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Infectious Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Asia Pacific Infectious Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Infectious Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Latin America Infectious Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Infectious Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Middle East and Africa Infectious Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
感染症治療薬の世界市場（～2026年） Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them. Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of in…- 感染症治療の世界市場（～2026年） Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Market Analysis and Insights: Global Infectious Disease Treatment M…
- 獣医感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Veterinary Infectious Disease Therapeutics Market The global Veterinary Infectious Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veterinary Infectious Disease…
- IVD感染症の世界市場（～2026年） In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.). Geographically, North America is the world's largest extracorporeal diagnostic market. Europe and the United S…
- 治療用ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Therapeutic Vaccines Market The global Therapeutic Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Therapeutic Vaccines Scope and Market Size Therapeutic Vaccines market is…